The Valence Group Advises Niacet on Its Sale to SK Capital

NEW YORK--()--The Valence Group has advised Niacet Corporation on its sale to SK Capital Partners. Financial terms of the transaction were not disclosed.

SK Capital is recapitalizing Niacet in partnership with Kelly Brannen, who will continue to serve as CEO and retain a significant stake in the Company. The transaction follows nearly four decades of Brannen family ownership after the purchase of Niacet from Union Carbide in 1978, during which time the Company grew significantly to become the worldwide leader in its core products.

About Niacet Corporation

Niacet is a leading producer of organic salts, including propionates and acetates, serving the food, feed, pharmaceutical and technical industries. With two fully automated manufacturing sites, located in Niagara Falls, NY and Tiel, The Netherlands, Niacet offers world-class quality products to global markets that fill vital needs in a broad range of applications that are essential to everyday life including food preservation, antibiotic formulation, dialysis treatment and energy production.

About The Valence Group

The Valence Group is a specialist investment bank offering M&A advisory services exclusively to companies and investors in the chemicals, materials and related sectors. The Valence Group team includes a unique combination of professionals with backgrounds in investment banking and strategy consulting within the chemicals and materials industries, all focused exclusively on providing M&A advisory services to the chemicals and materials sector. The firm’s offices are located in New York and London.

Contacts

The Valence Group
Paul Lakind, 212-847-7339
plakind@valencegroup.com

Release Summary

The Valence Group advises Niacet on its sale to SK Capital

Contacts

The Valence Group
Paul Lakind, 212-847-7339
plakind@valencegroup.com